Cargando…

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Data on the benefits of cardiac resynchronization therapy (CRT) in patients with severe heart failure (HF) symptoms are limited. We investigated the relative effects of CRT in patients with ambulatory NYHA IV vs. III functional class at the time of device implantation. In this meta-analysis, we pool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shivakumar, Nishkala, Friedman, Daniel J., Fudim, Marat, Abraham, William T., Cleland, John G. F., Curtis, Anne B., Gold, Michael R., Kutyifa, Valentina, Linde, Cecilia, Young, James, Tang, Anthony, Olivas-Martinez, Antonio, Inoue, Lurdes Y.T., Sanders, Gillian D., Al-Khatib, Sana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350149/ https://www.ncbi.nlm.nih.gov/pubmed/37461448 http://dx.doi.org/10.1101/2023.07.05.23292279

Ejemplares similares

Factors and outcomes associated with improved left ventricular systolic function in patients with cardiomyopathy
por: Eiger, Dylan S., et al.
Publicado: (2022)

Outcomes of Cardiac Resynchronization Therapy with Image-Guided Left Ventricular Lead Placement at the Site of Latest Mechanical Activation: A Systematic Review and Meta-Analysis
por: Allen LaPointe, Nancy M., et al.
Publicado: (2022)

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
por: Cleland, John G., et al.
Publicado: (2013)

Sex differences in left ventricular electrical dyssynchrony and outcomes with cardiac resynchronization therapy
por: Friedman, Daniel J., et al.
Publicado: (2020)

Cardiac resynchronization therapy in New York Heart Association class‐IV patients dependent on intravenous drugs or invasive supportive treatments
por: Lee, Seong Soo, et al.
Publicado: (2020)

Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)
por: St John Sutton, Martin, et al.
Publicado: (2015)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events
por: Szepietowska, Barbara, et al.
Publicado: (2016)

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy
por: Younis, Arwa, et al.
Publicado: (2021)

Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block
por: Biton, Yitschak, et al.
Publicado: (2015)

Stress Remains in the Eye of the Beholder
por: Shah, Kevin S., et al.
Publicado: (2020)

Tackling Inflammation in Heart Failure With Preserved Ejection Fraction: Resurrection of Vagus Nerve Stimulation?
por: Kittipibul, Veraprapas, et al.
Publicado: (2022)

Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure: Analysis of the ICD Registry and ADHERE
por: Khazanie, Prateeti, et al.
Publicado: (2014)

De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis
por: Kosztin, Annamaria, et al.
Publicado: (2017)

Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients
por: Nagy, Vivien Klaudia, et al.
Publicado: (2015)

The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal
por: Ellenbogen, Kenneth A, et al.
Publicado: (2023)

Novel findings of respiratory rate increases using the multisensor HeartLogic heart failure monitoring algorithm in COVID-19-positive patients: a case series
por: Yapejian, Andrea Rebecca, et al.
Publicado: (2021)

Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II
por: Koçyiğit, Duygu, et al.
Publicado: (2020)

Left-bundle branch block, an alert for cardiac resynchronization therapy
por: Gatti, P, et al.
Publicado: (2023)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Lateral left ventricular lead position is superior to posterior position in long‐term outcome of patients who underwent cardiac resynchronization therapy
por: Behon, Anett, et al.
Publicado: (2020)

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score
por: Tokodi, Márton, et al.
Publicado: (2020)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

What determines who gets cardiac resynchronization therapy in europe?
por: Gatti, P, et al.
Publicado: (2023)

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients
por: Kosztin, Annamaria, et al.
Publicado: (2016)

Lifting Coronavirus Disease-19 Shelter-in-Place Restrictions: Impact on Heart Failure Hospitalizations in Northeast Georgia
por: Ling, Hua, et al.
Publicado: (2020)

Turning Pressure Into Success: Preload Restriction in HFpEF?
por: Atkins, Jessica, et al.
Publicado: (2021)

Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
por: Fudim, Marat, et al.
Publicado: (2022)

Synchronized Diaphragmatic Stimulation for the Treatment of Symptomatic Heart Failure: A Novel Implantable Therapy Concept
por: Fudim, Marat, et al.
Publicado: (2022)

Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial
por: Merkely, Béla, et al.
Publicado: (2023)

Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy
por: Gold, Michael R., et al.
Publicado: (2018)

Hyperkalemia in Heart Failure: Probably Not O“K”
por: Fudim, Marat, et al.
Publicado: (2018)

Role of Volume Redistribution in the Congestion of Heart Failure
por: Fudim, Marat, et al.
Publicado: (2017)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
por: Branca, Luca, et al.
Publicado: (2020)

Blood volume and chronic kidney disease in heart failure – Can volume expansion help balance the Cardio‐Renal Axis for better clinical outcomes?
por: Miller, Wayne L., et al.
Publicado: (2022)

Shielding the Heart: Preload Reduction Therapies in Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2023)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial
por: Wikstrom, Gerhard, et al.
Publicado: (2009)

Anodal Stimulation: An Underrecognized Cause of Nonresponders to Cardiac Resynchronization Therapy
por: Dendy, Khalin F, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3nqu2kb556t1hu0ecb481jihrc